12/9/2023 0 Comments Amana kitchen appliance packagesRisk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study.Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.Protocol: Investigating the uptake, effectiveness and safety of COVID-19 vaccines.First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis.Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic.Vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era.Pre-print: Vaccine Effectiveness of Two-Dose BNT162b2 Against COVID-19 Symptomatic Infection and Severe Cases Among Adolecents.Pre-print: Waning of BNT162b2 or ChadOx1 mRNA Boosters against symptomatic infection and severe COVID-19 in Brazil and Scotland.Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II).Impact on emergency and elective hospital-based care in Scotland over the first year of the pandemic.Impact of first UK COVID-19 lockdown on hospital admissions in England, Scotland and Wales.Protocol: Common protocol for validation of the QCOVID algorithm across the four UK nations.Pre-print: Obesity is associated with reduced SARS-CoV-2 vaccine efficacy.COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2.Effectiveness of Two-Dose Pfizer-BioNTech vaccine among Adolescents in Scotland and Brazil.Second-dose Oxford-AstraZeneca and Pfizer-BioNTech vaccines and blood clotting and bleeding events in Scotland.Letter: Characterising adults in Scotland who are not vaccinated against COVID-19.Risk of COVID-19 hospitalizations among school-aged children in Scotland.BNT162b2 uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland.COPS: Pregnancy outcomes following Delta and Omicron SARS-CoV-2 infection in Scotland.Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters.COPS: Early Pregnancy Outcomes following COVID-19 Vaccination and SARS-COV-2 Infection in Pregnant Women.Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations across the UK.Letter: Severity of Omicron BA.2 variant and vaccine effectiveness against symptomatic disease in Scotland.Spotlight: Patient collaboration in COVID-19 research: translating ideas to reality.Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study.Letter: Uptake of monoclonal antibodies and anti-viral therapies for COVID-19 in Scotland.COPS: Confirmed SARS-CoV-2 infection in Scottish newborns 2020–2022.COPS: Study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection.Effectiveness of mRNA boosters against symptomatic infection and severe COVID-19 in Brazil and Scotland.Pre-print: Impact of antiviral and monoclonal antibody treatments on serious COVID-19 outcomes.Pre-print: Identifying Long Covid Using Electronic Health Records.Accelerated waning of COVID-19 vaccines due to obesity.Pre-print: Association between antibody responses post-vaccination and severe COVID-19 outcomes.Vaccine effectiveness and severity of Omicron BA.5 variant on COVID-19 outcomes in Scotland.Increased risk of COVID-19 outcomes among minority ethnic groups within Scotland.Predicting incomplete COVID-19 vaccination schedules in Scotland.Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination. ![]() Understanding and reporting odds ratios as rate-ratio estimates in case-control studies.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |